TAK

Takeda Pharmaceutical Company Limited
D

TAK

13.020
USD
-0.09
(-0.65%)
Market Open
Volume
5,642
EPS
133
Div Yield
4.72
P/E
22
Market Cap
41,293,954,474
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    AMGN
    -1.01
    (-0.37%)
    273.74 USD
    AZN
    AZN
    0.200
    (0.29%)
    68.060 USD
    GSK
    GSK
    -0.095
    (-0.28%)
    33.685 USD
    LLY
    LLY
    9.28
    (1.25%)
    752.93 USD
    MRK
    MRK
    -0.490
    (-0.51%)
    95.890 USD
    NVO
    NVO
    0.525
    (0.65%)
    81.360 USD
    PFE
    PFE
    -0.226
    (-0.85%)
    26.390 USD
    REGN
    REGN
    7.35
    (1.07%)
    694.67 USD
    SNY
    SNY
    -0.110
    (-0.21%)
    51.500 USD
    More
News

Title: Takeda Pharmaceutical Company Limited

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.